announcements

YIRG Announcement

The National Lung Cancer Partnership is pleased to announce our 5th annual research grant competition. This year, four, 2-year $100,000 awards are available to clinical and basic science fellows and junior faculty to advance their research in lung cancer etiology, prevention, early detection, treatment, and symptom management. Three grants will be co-funded with the LUNGevity Foundation, with the assistance of Genentech and Sanofi-Aventis, and one grant will be funded by the North Carolina Lung Cancer Partnership.

The purpose of these awards is to drive forward research that will increase understanding of lung cancer risk, biology, and response to treatment, in an effort to fulfill the Partnership’s mission of decreasing deaths due to the disease and helping patients live longer and better lives.

At the time of application, an applicant must hold a doctoral degree (MD, PhD, DO, DrPH, or equivalent), and be a post-doctoral fellow or within the first 5 years of a faculty appointment at a not-for-profit institution in the United States or Canada. Applications addressing sex differences in lung cancer are particularly encouraged. Applicants will be judged on the merits of their research proposal, career development plan, and research environment.

For complete application eligibility and instructions for the awards, please visit the National Lung Cancer Partnership’s website atwww.NationalLungCancerPartnership.org. The application deadline is September 8, 2009. Awards will be announced on or before January 1, 2010.

Fellowship Awards

IASLC Lung Cancer Fellowship Award/Young Investigators Award - 2 years duration

IASLC/PCF Prevent Cancer Foundation Fellowship Award - 2 years duration

IASLC/National Lung Cancer Partnership Fellowship Award - 2 years duration

See Guidelines for Fellowships

The IASLC is proud to announce a continuation and expansion of the IASLC Fellowship and Young Investigators Programs.

Overall there are 18 potential awards for two years each. There are awards in prevention and translational lung cancer research that are jointly sponsored with the Prevent Cancer Foundation, (PCF), through educational grants from Eli Lilly. There are unrestricted awards in any field of lung cancer research supported by educational grants from National Lung Cancer Partnership, GlaxoSmithKline, Sanofi-Aventis, AstraZeneca, Celgene, Pfizer, Eli Lilly, and OSI.

This year 6 new unrestricted awards of $40,000 each year for 2 years were available for competition. 

The goal is to reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research and translational research with a potential impact on the management of lung cancer. The applications are evaluated by a Scientific Review Panel.

Download the Application form here Adobe Acrobat

Download the Application in Word format
Please email your application to pia.hirsch@ucdenver.edu

 

[Top of Page]

IASLC Invitation to host
16th World Conference on Lung Cancer 2015

The IASLC World Conference is soliciting bids for the 16th World Conference on Lung Cancer to take place in North America.
The IASLC World Conference on Lung Cancer is held every second year and will take place in  North American 15.  The attendance can be expected to range from 8,000 – 10,000 (including accompanying persons)

The proposal should include the following:

  • Location

  • The 16th World Conference will take place in a North America country.

  • Time period

  • The duration of the Conference is 4-5 days.

  • Facilities (for conferences, workshops, hotels, etc.)

  • The meeting must take place in a location with adequate facilities to comfortably accommodate the expected attendance (up to 10,000)

  • Flight connections must be accessible from anywhere in the world.

  • Organizers

  • The group should include persons with a demonstrated track record within the IASLC who can put together a small local Organizing Program Committee to coordinate the planning of the meeting, and they should preferably have previous experience with similar arrangements.

  • Local/national support

  • If possible, support should be requested from national societies or local organizers.

  • Budget proposal

  • A detailed budget must outline all expected revenues and expenses.

  • Suggestions for social events

A copy of the detailed ‘Guidelines for the International Association for the Study of Lung Cancer World Conferences’ can be obtained from the IASLC website www.iaslc.org.

Applications will be accepted after September 2008, and not later than December 1, 2008. The applications will be reviewed by the IASLC Board of Directors at the Board meeting in February 2008. Finalists will be notified in March 2008 and selected IASLC Officers, staff, Board members will conduct site visits to the finalist sites in the spring of 2009. A final decision will be made no later than the Board meeting in June 2009.

Further information can be obtained from members of the Board and from the IASLC Office.
Please apply by e-mail pia.hirsch@uchsc.edu latest December 1st, 2008.
by mail:
International Association for the Study of Lung Cancer
Executive Director Paul A. Bunn, Jr., MD
University of Colorado Cancer Center

P.O.Box 6508, MS F 434, Aurora, Colorado 80045-0511, USA

Download the WCLC Guidelines here Adobe Acrobat

[Top of Page]

2009 Board of Director Nominations

In 2009 there will be an election for a President-Elect from Europe and 15 Board members with 5 each from North America, Europe, and Asia/Rest of World (ROW). The members should be diverse in terms of specialty and gender.

The following Board of Directors will remain as elected members of the Board from 2009-2011:

North America
Joan Schiller, Medical Oncology
Harvey Pass, Surgery

Europe
Elisabeth Brambilla, Pathology
Wilfried Eberhardt, Medical Oncology

Asia/ROW
Tony Mok, Medical Oncology
Kwun Fong, Medical Oncology
Masahiro Tsuboi, Surgery

Thus, the IASLC membership will need to elect 3 Board members from North America, 3 from Europe, and 2 from Asia/ROW.

The Nominating Committee is seeking nominations for the Board. You may nominate yourself or another IASLC member to one of these positions.

To nominate an individual, please complete the Nomination Form and forward to the IASLC Executive Office by November 15, 2008. The form may be sent as an email attachment to pia.hirsch@uchsc.edu or by fax to 303-724-3162.

[Top of Page]

Career Opportunities in Thoracic Oncology

If you have a position to list on this website, please email your request with all of the pertinent information.

Medical Director, Lung Cancer - USA
The Lombardi Cancer Center and Georgetown University Hospital are seeking a new Medical Director to lead their Lung Cancer program. Successful candidates will have an MD or MD/PhD degree with board certification in medical oncology with an established and published track record as a leading lung cancer researcher. Successful candidates may currently be an Assistant Professor or Professor of Medical Oncology.

Please review the full description.

NCIC CTG Thoracic Oncology Clinical Trials Fellowship - Canada
The National Cancer Institute of Canada Clincal Trials Group at Queens University is accepting applications for a Thoracic Oncology Clinical Trials Fellowship. This 2 year position is open to motivated individuals who have preferably completed Surgical, Medical, or Radiation Oncology training nationally or internationally.

Please review the full description.

[Top of Page]